| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Clínica Baviera, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €38.70 |
| 52 Week High | €39.30 |
| 52 Week Low | €19.20 |
| Beta | 0.67 |
| 11 Month Change | 10.57% |
| 3 Month Change | 34.38% |
| 1 Year Change | 97.45% |
| 33 Year Change | 106.95% |
| 5 Year Change | 180.43% |
| Change since IPO | 70.79% |
Recent News & Updates
Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital
Oct 18
Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
Sep 19Market Cool On Clínica Baviera, S.A.'s (BME:CBAV) Earnings
Jul 13Recent updates
Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital
Oct 18Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
Sep 19Market Cool On Clínica Baviera, S.A.'s (BME:CBAV) Earnings
Jul 13Clínica Baviera (BME:CBAV) Might Become A Compounding Machine
Mar 01Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405
Nov 20Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital
Jan 20These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely
Sep 15Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)
Apr 12Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
Mar 21Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 22Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return
Jan 30Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital
Jan 09
Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative
Dec 19Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet
Nov 28Shareholder Returns
| CBAV | ES Healthcare | ES Market | |
|---|---|---|---|
| 7D | 7.2% | 1.1% | 1.3% |
| 1Y | 97.4% | 13.1% | 29.5% |
Return vs Industry: CBAV exceeded the Spanish Healthcare industry which returned 13.1% over the past year.
Return vs Market: CBAV exceeded the Spanish Market which returned 29.5% over the past year.
Price Volatility
| CBAV volatility | |
|---|---|
| CBAV Average Weekly Movement | 4.4% |
| Healthcare Industry Average Movement | 4.3% |
| Market Average Movement | 2.9% |
| 10% most volatile stocks in ES Market | 5.4% |
| 10% least volatile stocks in ES Market | 0.6% |
Stable Share Price: CBAV's share price has been volatile over the past 3 months compared to the Spanish market.
Volatility Over Time: CBAV's weekly volatility (4%) has been stable over the past year, but is still higher than 75% of Spanish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,326 | Eduardo Baviera Sabater | www.clinicabaviera.com |
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments.
Clínica Baviera, S.A. Fundamentals Summary
| CBAV fundamental statistics | |
|---|---|
| Market cap | €630.90m |
| Earnings (TTM) | €38.41m |
| Revenue (TTM) | €243.31m |
16.4x
P/E Ratio2.6x
P/S RatioIs CBAV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBAV income statement (TTM) | |
|---|---|
| Revenue | €243.31m |
| Cost of Revenue | €122.92m |
| Gross Profit | €120.39m |
| Other Expenses | €81.98m |
| Earnings | €38.41m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.36 |
| Gross Margin | 49.48% |
| Net Profit Margin | 15.79% |
| Debt/Equity Ratio | 1.9% |
How did CBAV perform over the long term?
See historical performance and comparison